… The sentinel lymph node biopsy sensitivity is more than 90%, its specificity 100%, its
accuracy more than 95%, and the axillary recurrence rate is less than 1%. There are still though …

… Some data support the policy that all blue staining nodes should be harvested for optimal
SLN staging, while international guidelines lack a unique definition for surgical detection of …

… breast carcinoma. Historically, all patients with a positive sentinel lymph node biopsy result
underwent axillary lymph … Some cases may require multidisciplinary team discussion. …

… If the indications of sentinel lymph node biopsy and axillary lymph node dissection have …
, in the absence of axillary lymph node dissection are a matter of debate. We reviewed the …

… Results of multiple studies support the conclusion that all injection modalities enable axillary
SLN(s) to be identified accurately, and satisfactory SLN detection rates have been reported …

… in patients with invasive breast cancer. Because our group performed this type of analysis
opens the subject to critical analysis and debate among other cancer experts and may be …

… node together with patients having two or more nodes positive. One other issue that often
confuses the discussion of … in a sentinel node; this is not the topic of the current discussion. The …

… The results of the NSABP B-32 clinical trial support the current guidelines for examination
of SLNs from patients with breast carcinoma. The College of American Pathologists (CAP) …

… have resulted in less than a 1% false-negative rate, which would argue strongly for
intraparenchymal injection of the mapping agents.30, 35 Other compelling observations support …

… The status of the sentinel lymph node (SLN) has … breast cancer. This study was designed
to determine the optimal protocol for SLN processing. A total of 173 SLNs from 96 breast cancer …